scholarly journals Genome-wide expression profiling of long non-coding RNAs and competing endogenous RNA networks in alopecia areata

2021 ◽  
Vol 18 (1) ◽  
pp. 696-711
Author(s):  
Sisi Qi ◽  
◽  
Youyu Sheng ◽  
Ruiming Hu ◽  
Feng Xu ◽  
...  
Keyword(s):  
Alopecia Areata ◽  
Expression Profiling ◽  
Competing Endogenous Rna ◽  
Genome Wide ◽  
Non Coding Rnas ◽  
Genome Wide Expression

Genome-wide expression profiling of ARABIDOPSIS RESPONSE REGULATOR 7(ARR7) overexpression in cytokinin response

2006 ◽  
Vol 277 (2) ◽  
pp. 115-137 ◽  
Author(s):  
Dong Ju Lee ◽  
Jin-Young Park ◽  
Su-Jin Ku ◽  
Young-Min Ha ◽  
Sunmi Kim ◽  
...  
Keyword(s):  
Expression Profiling ◽  
Response Regulator ◽  
Genome Wide ◽  
Cytokinin Response ◽  
Genome Wide Expression

scholarly journals Genome-wide expression profiling of glioblastoma using a large combined cohort

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Jing Tang ◽  
Dian He ◽  
Pingrong Yang ◽  
Junquan He ◽  
Yang Zhang
Keyword(s):  
Expression Profiling ◽  
Genome Wide ◽  
Genome Wide Expression

scholarly journals Genome-wide Expression Profiling in Ponkan Infected by Candidatus Liberibacter asiaticus

2014 ◽  
Vol 1 (1) ◽  
Author(s):  
Bo Jiang ◽  
Yun Zhong ◽  
Chunzhen Cheng ◽  
Jiwu Zeng ◽  
Guangyan Zhong ◽  
...  
Keyword(s):  
Expression Profiling ◽  
Candidatus Liberibacter Asiaticus ◽  
Genome Wide ◽  
Candidatus Liberibacter ◽  
Liberibacter Asiaticus ◽  
Genome Wide Expression

Cancer of unknown primary site

2016 ◽  
pp. 965-974
Author(s):  
Nicholas Pavlidis ◽  
George Pentheroudakis
Keyword(s):  
Expression Profiling ◽  
Cancer Of Unknown Primary ◽  
Primary Site ◽  
Unknown Primary ◽  
Unknown Primary Site ◽  
Clinical Intuition ◽  
Genome Wide ◽  
Genetic Signatures ◽  
Genome Wide Expression ◽  
Tumour Origin

This chapter covers cancer of unknown primary site (CUP), and includes information on epidemiology, molecular biology, pathology, and multidisciplinary management of clinicopathological subsets. Previously, these tumours were diagnosed and treated based on clinical presentation, light microscopy and clinical intuition. Today, the majority of cancers of unknown primary site are becoming less unknown, more accurately classified, and appropriately treated by the use of multiplex or genome-wide expression profiling platforms. These techniques allow for precise and correct knowledge of the true tumour origin, leading to more rational and effective treatment. However, there also may be genetic signatures that are primary-independent, pro-metastatic, and possibly CUP-specific.

Sign in / Sign up

Export Citation Format

Share Document